Imagine a world where bacteria, typically feared for causing disease, are turned into powerful weapons against cancer. That's ...

I knew I was kind of a guinea pig, but the only other option was staying at home, and I wasn’t going to make it,” Tim Story ...

A cancer charity has said it is "angry and frustrated" that ministers and health officials have not approved the provision of ...

Pliant Therapeutics' PLN-101095 showed partial responses in ICI-refractory tumors, with a 50% ORR at the highest dose tested ...

The inquiry is the latest effort by the European Commission and European countries to scrutinize potential antitrust behavior ...

Scientists from the University of Auckland have discovered that a cancer drug called alpelisib may help extend lifespan—at ...

Six months after publicly revealing his “incurable” cancer diagnosis to the nation, Nigel Latta has said he’s responded well ...

When experienced researcher Renato Aguilera happened across the chemical structure of a tried-and-true antimalarial drug one ...

While PD-1/PD-L1 blockade has demonstrated remarkable clinical successes, recent studies suggest that its novel target has a ...

Researchers have identified a previously unknown bacterial protein, the structure of which is being used in the design of protein nanoparticles for the targeted delivery of anticancer drugs to tumors.

The company has asked the U.S. patent office to reconsider patents that could prevent it from selling an update to Keytruda.

A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer, data ...